Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | RLAY | Relay Therapeutics Inc. | Healthcare | 2,232,451.0 | $18.9M | 2.16% | NEW | — | $8.46 | +109.6% |
| 22 | GLUE | Monte Rosa Therapeutics Inc | Healthcare | 1,173,376.0 | $18.4M | 2.10% | NEW | — | $15.68 | -25.3% |
| 23 | — | Bright Minds Biosciences Inc | — | 230,147.0 | $18.0M | 2.06% | NEW | — | $78.04 | — |
| 24 | PTGX | Protagonist Therapeutics Inc | Healthcare | 199,471.0 | $17.4M | 1.99% | NEW | — | $87.34 | +57.2% |
| 25 | — | enGene Holdings, Inc. | — | 1,840,898.0 | $16.6M | 1.90% | NEW | — | $9.03 | — |
| 26 | CNTX | Context Therapeutics Inc | Healthcare | 10,679,391.0 | $15.7M | 1.80% | NEW | — | $1.47 | -74.8% |
| 27 | ARQT | Arcutis Biotherapeutics Inc | Healthcare | 531,200.0 | $15.4M | 1.76% | NEW | — | $29.04 | -9.5% |
| 28 | — | Ventyx Biosciences Inc | — | 1,639,061.0 | $14.8M | 1.69% | NEW | — | $9.03 | — |
| 29 | ORIC | Oric Pharmaceuticals Inc | Healthcare | 1,798,717.0 | $14.7M | 1.68% | NEW | — | $8.18 | +61.1% |
| 30 | BLTE | Belite Bio Inc | Healthcare | 87,760.0 | $14.0M | 1.61% | NEW | — | $159.96 | +5.9% |
| 31 | — | RAPT Therapeutics Inc | — | 397,906.0 | $13.5M | 1.54% | NEW | — | $33.87 | — |
| 32 | — | Climb Bio Inc | — | 2,671,480.0 | $10.7M | 1.22% | NEW | — | $4.00 | — |
| 33 | ABVX | Abivax SA | Healthcare | 56,316.0 | $7.6M | 0.87% | NEW | — | $134.85 | -29.7% |
| 34 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 1,586,076.0 | $5.6M | 0.64% | NEW | — | $3.51 | -23.4% |
| 35 | MAZE | Maze Therapeutics Inc | Healthcare | 81,145.0 | $3.4M | 0.39% | NEW | — | $41.43 | -36.7% |
| 36 | EVMN | Evommune Inc | Healthcare | 113,022.0 | $1.9M | 0.22% | NEW | — | $17.12 | -48.6% |
| 37 | SRPT | Sarepta Therapeutics Inc | Healthcare | 70,000.0 | $1.5M | 0.17% | NEW | — | $21.52 | -14.5% |
| 38 | HOWL | Werewolf Therapeutics, Inc. | Healthcare | 1,393,557.0 | $884K | 0.10% | NEW | — | $0.63 | +54.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%